IRS1 and Alzheimer disease: Our results are congruent with the body of reports showing an increase in IRS-1 phosphorylation at the serine (Ser) 312 and 616 sites in AD pathogenesis, whereas under normal signaling conditions, IRS-1 is phosphorylated at the tyrosine site.